Your browser doesn't support javascript.
loading
Absorption, distribution, metabolism and excretion of an isocitrate dehydrogenase-2 inhibitor enasidenib in rats and humans.
Tong, Zeen; Atsriku, Christian; Yerramilli, Usha; Wang, Xiaomin; Li, Yan; Reyes, Josephine; Fan, Bin; Yang, Hua; Hoffmann, Matthew; Surapaneni, Sekhar.
Afiliação
  • Tong Z; a Nonclinical Development , Celgene Corporation , Summit , NJ , USA.
  • Atsriku C; a Nonclinical Development , Celgene Corporation , Summit , NJ , USA.
  • Yerramilli U; a Nonclinical Development , Celgene Corporation , Summit , NJ , USA.
  • Wang X; a Nonclinical Development , Celgene Corporation , Summit , NJ , USA.
  • Li Y; b Clinical Pharmacology , Celgene Corporation , Summit , NJ , USA , and.
  • Reyes J; b Clinical Pharmacology , Celgene Corporation , Summit , NJ , USA , and.
  • Fan B; c DMPK/Clinical Pharmacology , Agios Pharmaceutical , Cambridge , MA , USA.
  • Yang H; c DMPK/Clinical Pharmacology , Agios Pharmaceutical , Cambridge , MA , USA.
  • Hoffmann M; a Nonclinical Development , Celgene Corporation , Summit , NJ , USA.
  • Surapaneni S; a Nonclinical Development , Celgene Corporation , Summit , NJ , USA.
Xenobiotica ; 49(2): 200-210, 2019 Feb.
Article em En | MEDLINE | ID: mdl-29320949

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Triazinas / Aminopiridinas / Antineoplásicos Limite: Animals / Humans Idioma: En Revista: Xenobiotica Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Triazinas / Aminopiridinas / Antineoplásicos Limite: Animals / Humans Idioma: En Revista: Xenobiotica Ano de publicação: 2019 Tipo de documento: Article